Cargando…
Correction to: No effects of COVID‑19 on the development of type 1 diabetes autoimmunity and no evidence of an increased frequency of SARS‑CoV‑2 antibodies in newly diagnosed type 1 diabetes patients relative to healthy subjects
| Autores principales: | , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Springer Milan
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10442254/ https://www.ncbi.nlm.nih.gov/pubmed/37474814 http://dx.doi.org/10.1007/s00592-023-02152-6 |
| _version_ | 1785093551902687232 |
|---|---|
| author | Tiberti, Claudio Nenna, Raffaella Tromba, Valeria Filardi, Tiziana Petrarca, Laura Silvestri, Francesca Fassino, Valeria Montuori, Monica Mancino, Enrica Lenzi, Andrea Midulla, Fabio Costantino, Francesco Morano, Susanna |
| author_facet | Tiberti, Claudio Nenna, Raffaella Tromba, Valeria Filardi, Tiziana Petrarca, Laura Silvestri, Francesca Fassino, Valeria Montuori, Monica Mancino, Enrica Lenzi, Andrea Midulla, Fabio Costantino, Francesco Morano, Susanna |
| author_sort | Tiberti, Claudio |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-10442254 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | Springer Milan |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-104422542023-08-23 Correction to: No effects of COVID‑19 on the development of type 1 diabetes autoimmunity and no evidence of an increased frequency of SARS‑CoV‑2 antibodies in newly diagnosed type 1 diabetes patients relative to healthy subjects Tiberti, Claudio Nenna, Raffaella Tromba, Valeria Filardi, Tiziana Petrarca, Laura Silvestri, Francesca Fassino, Valeria Montuori, Monica Mancino, Enrica Lenzi, Andrea Midulla, Fabio Costantino, Francesco Morano, Susanna Acta Diabetol Correction Springer Milan 2023-07-20 2023 /pmc/articles/PMC10442254/ /pubmed/37474814 http://dx.doi.org/10.1007/s00592-023-02152-6 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
| spellingShingle | Correction Tiberti, Claudio Nenna, Raffaella Tromba, Valeria Filardi, Tiziana Petrarca, Laura Silvestri, Francesca Fassino, Valeria Montuori, Monica Mancino, Enrica Lenzi, Andrea Midulla, Fabio Costantino, Francesco Morano, Susanna Correction to: No effects of COVID‑19 on the development of type 1 diabetes autoimmunity and no evidence of an increased frequency of SARS‑CoV‑2 antibodies in newly diagnosed type 1 diabetes patients relative to healthy subjects |
| title | Correction to: No effects of COVID‑19 on the development of type 1 diabetes autoimmunity and no evidence of an increased frequency of SARS‑CoV‑2 antibodies in newly diagnosed type 1 diabetes patients relative to healthy subjects |
| title_full | Correction to: No effects of COVID‑19 on the development of type 1 diabetes autoimmunity and no evidence of an increased frequency of SARS‑CoV‑2 antibodies in newly diagnosed type 1 diabetes patients relative to healthy subjects |
| title_fullStr | Correction to: No effects of COVID‑19 on the development of type 1 diabetes autoimmunity and no evidence of an increased frequency of SARS‑CoV‑2 antibodies in newly diagnosed type 1 diabetes patients relative to healthy subjects |
| title_full_unstemmed | Correction to: No effects of COVID‑19 on the development of type 1 diabetes autoimmunity and no evidence of an increased frequency of SARS‑CoV‑2 antibodies in newly diagnosed type 1 diabetes patients relative to healthy subjects |
| title_short | Correction to: No effects of COVID‑19 on the development of type 1 diabetes autoimmunity and no evidence of an increased frequency of SARS‑CoV‑2 antibodies in newly diagnosed type 1 diabetes patients relative to healthy subjects |
| title_sort | correction to: no effects of covid‑19 on the development of type 1 diabetes autoimmunity and no evidence of an increased frequency of sars‑cov‑2 antibodies in newly diagnosed type 1 diabetes patients relative to healthy subjects |
| topic | Correction |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10442254/ https://www.ncbi.nlm.nih.gov/pubmed/37474814 http://dx.doi.org/10.1007/s00592-023-02152-6 |
| work_keys_str_mv | AT tiberticlaudio correctiontonoeffectsofcovid19onthedevelopmentoftype1diabetesautoimmunityandnoevidenceofanincreasedfrequencyofsarscov2antibodiesinnewlydiagnosedtype1diabetespatientsrelativetohealthysubjects AT nennaraffaella correctiontonoeffectsofcovid19onthedevelopmentoftype1diabetesautoimmunityandnoevidenceofanincreasedfrequencyofsarscov2antibodiesinnewlydiagnosedtype1diabetespatientsrelativetohealthysubjects AT trombavaleria correctiontonoeffectsofcovid19onthedevelopmentoftype1diabetesautoimmunityandnoevidenceofanincreasedfrequencyofsarscov2antibodiesinnewlydiagnosedtype1diabetespatientsrelativetohealthysubjects AT filarditiziana correctiontonoeffectsofcovid19onthedevelopmentoftype1diabetesautoimmunityandnoevidenceofanincreasedfrequencyofsarscov2antibodiesinnewlydiagnosedtype1diabetespatientsrelativetohealthysubjects AT petrarcalaura correctiontonoeffectsofcovid19onthedevelopmentoftype1diabetesautoimmunityandnoevidenceofanincreasedfrequencyofsarscov2antibodiesinnewlydiagnosedtype1diabetespatientsrelativetohealthysubjects AT silvestrifrancesca correctiontonoeffectsofcovid19onthedevelopmentoftype1diabetesautoimmunityandnoevidenceofanincreasedfrequencyofsarscov2antibodiesinnewlydiagnosedtype1diabetespatientsrelativetohealthysubjects AT fassinovaleria correctiontonoeffectsofcovid19onthedevelopmentoftype1diabetesautoimmunityandnoevidenceofanincreasedfrequencyofsarscov2antibodiesinnewlydiagnosedtype1diabetespatientsrelativetohealthysubjects AT montuorimonica correctiontonoeffectsofcovid19onthedevelopmentoftype1diabetesautoimmunityandnoevidenceofanincreasedfrequencyofsarscov2antibodiesinnewlydiagnosedtype1diabetespatientsrelativetohealthysubjects AT mancinoenrica correctiontonoeffectsofcovid19onthedevelopmentoftype1diabetesautoimmunityandnoevidenceofanincreasedfrequencyofsarscov2antibodiesinnewlydiagnosedtype1diabetespatientsrelativetohealthysubjects AT lenziandrea correctiontonoeffectsofcovid19onthedevelopmentoftype1diabetesautoimmunityandnoevidenceofanincreasedfrequencyofsarscov2antibodiesinnewlydiagnosedtype1diabetespatientsrelativetohealthysubjects AT midullafabio correctiontonoeffectsofcovid19onthedevelopmentoftype1diabetesautoimmunityandnoevidenceofanincreasedfrequencyofsarscov2antibodiesinnewlydiagnosedtype1diabetespatientsrelativetohealthysubjects AT costantinofrancesco correctiontonoeffectsofcovid19onthedevelopmentoftype1diabetesautoimmunityandnoevidenceofanincreasedfrequencyofsarscov2antibodiesinnewlydiagnosedtype1diabetespatientsrelativetohealthysubjects AT moranosusanna correctiontonoeffectsofcovid19onthedevelopmentoftype1diabetesautoimmunityandnoevidenceofanincreasedfrequencyofsarscov2antibodiesinnewlydiagnosedtype1diabetespatientsrelativetohealthysubjects |